止咳糖漿市場規模、佔有率和成長分析（按產品、年齡層、分佈和地區）- 行業預測，2025-2032 年

2023 年全球止咳糖漿市場規模價值 52 億美元，預計將從 2024 年的 54.1 億美元成長到 2032 年的 74 億美元，預測期內（2025-2032 年）的複合年成長率為 4.0%。

由於各大製藥公司對創新配方研發的大量投資，全球止咳糖漿市場呈現良好的成長軌跡。消費者對及時處理咳嗽相關問題的認知不斷提高，進一步推動了市場擴張。公司正在利用策略聯盟、產品發布和有針對性的行銷努力來提高其競爭地位。網上購物平台的便利性也增加了市場可近性，使消費者更容易探索多樣化的產品選擇。從區域來看，所有地區的需求都在顯著成長，尤其是醫療基礎設施不斷發展、可支配收入不斷提高的新興市場。此外，向草藥和天然替代品的轉變正在重塑市場動態。儘管存在監管挑戰和對濫用的擔憂，市場前景仍然樂觀。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

止咳糖漿市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 祛痰藥
• 止咳藥
• 抗組織胺藥
• 伴隨用藥

止咳糖漿市場規模（依年齡層分類）及複合年成長率（2025-2032 年）

• 市場概況
• 孩子們
• 成人

止咳糖漿市場規模（按分銷管道和複合年成長率） (2025-2032)

• 市場概況
• 零售
• 藥局
• 醫院
• 其他

止咳糖漿市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Johnson & Johnson（USA）
• Pfizer Inc.（USA）
• GlaxoSmithKline plc（UK）
• Sanofi SA（France）
• Bayer AG（Germany）
• Reckitt Benckiser Group plc（UK）
• Procter & Gamble（USA）
• Prestige Consumer Healthcare Inc.（USA）
• Church & Dwight Co., Inc.（USA）
• Dabur India Ltd.（India）
• Himalaya Wellness Company（India）
• Cipla Ltd.（India）
• Sun Pharmaceutical Industries Ltd.（India）
• Mankind Pharma Ltd.（India）
• Perrigo Company plc（Ireland）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Mylan NV（USA）
• Perrigo Company plc（Ireland）
• Valeant Pharmaceuticals International, Inc.（Canada）
• Medtech Products Inc.（USA）

結論和建議

Global Cough Syrup Market size was valued at USD 5.2 billion in 2023 and is poised to grow from USD 5.41 billion in 2024 to USD 7.4 billion by 2032, growing at a CAGR of 4.0% during the forecast period (2025-2032).

The Global Cough Syrup Market is on a promising growth trajectory, driven by significant investments from major pharmaceutical companies in research and development of innovative formulations. Increased consumer awareness regarding the prompt management of cough-related issues further fuels market expansion. Companies are leveraging strategic partnerships, product launches, and targeted marketing efforts to enhance their competitive positions. The convenience of online purchasing platforms also boosts market accessibility, enabling consumers to explore diverse product options easily. Geographically, all regions are experiencing notable increases in demand, especially in emerging economies with advancing healthcare infrastructure and rising disposable incomes. Additionally, the shift towards herbal and natural alternatives is reshaping market dynamics. Despite regulatory challenges and concerns over misuse, the market outlook remains positive.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cough Syrup market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cough Syrup Market Segmental Analysis

Global Cough Syrup Market is segmented by Product, Age Group, Distribution and region. Based on Product, the market is segmented into Expectorants, Cough Suppressants, Antihistamines and Combination Medication. Based on Age Group, the market is segmented into Pediatric and Adult. Based on Distribution, the market is segmented into Retail, Pharmacy, Hospital and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cough Syrup Market

A significant factor fueling the global cough syrup market is the rising incidence of respiratory disorders across the globe. The surge in respiratory ailments can be attributed to several factors, including escalating air pollution levels, fluctuating weather patterns, and the widespread transmission of viral infections. These elements collectively result in a higher occurrence of cough and cold-related symptoms among populations, consequently driving demand for cough syrups as a reliable treatment option. As more individuals seek relief from these common yet bothersome ailments, the cough syrup market is expected to experience continued growth and expansion.

Restraints in the Global Cough Syrup Market

One of the major constraints facing the global cough syrup market is the stringent regulations aimed at preventing the misuse of these products, especially those that contain codeine or other addictive components. Authorities and governments worldwide are increasingly enforcing strict controls and imposing prescription requirements to combat potential abuse and misuse of cough syrups. These regulations are intended to safeguard public health but can inadvertently restrict access to these medications for legitimate consumers. Consequently, such limitations may hinder the overall growth potential of the cough syrup market, as manufacturers must navigate a complex landscape of compliance and risk management.

Market Trends of the Global Cough Syrup Market

The Global Cough Syrup market is witnessing a significant shift towards natural and plant-based formulations, driven by heightened consumer awareness regarding health and wellness. As more individuals prioritize holistic health solutions, there is a marked increase in demand for cough syrups containing herbal extracts and other natural ingredients, which are perceived as safer alternatives to synthetic products. This trend reflects a growing consumer preference for sustainable and effective healthcare options, with an emphasis on the efficacy of natural remedies in alleviating cough and cold symptoms. Consequently, manufacturers are focusing on developing innovative, eco-friendly cough syrup products to cater to this evolving consumer landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cough Syrup Market Size by Product & CAGR (2025-2032)

• Market Overview
• Expectorants
• Cough Suppressants
• Antihistamines
• Combination Medication

Global Cough Syrup Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Pediatric
• Adult

Global Cough Syrup Market Size by Distribution & CAGR (2025-2032)

• Market Overview
• Retail
• Pharmacy
• Hospital
• Others

Global Cough Syrup Market Size & CAGR (2025-2032)

• North America (Product, Age Group, Distribution)
  • US
  • Canada
• Europe (Product, Age Group, Distribution)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Age Group, Distribution)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Age Group, Distribution)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Age Group, Distribution)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Procter & Gamble (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prestige Consumer Healthcare Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Church & Dwight Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dabur India Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Himalaya Wellness Company (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mankind Pharma Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valeant Pharmaceuticals International, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtech Products Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations